Education
About Us
Working with TipRanks
Follow Us
Allarity Therapeutics, Inc. (ALLR)
:ALLR
ALLR Stock Chart & Stats
$1.06
-$0.01(-0.99%)
At close: 4:00 PM EST
$1.06
-$0.01(-0.99%)
Day’s Range― - ―
52-Week Range$0.61 - $2.35
Previous CloseN/A
Volume542.33K
Average Volume (3M)215.78K
Market Cap
$19.76M
Enterprise Value$7.78M
Total Cash (Recent Filing)$16.89M
Total Debt (Recent Filing)$1.39M
Price to Earnings (P/E)―
Beta1.18
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding15,811,886
10 Day Avg. Volume165,507
30 Day Avg. Volume215,784
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.16
Price to Sales (P/S)0.00
P/FCF Ratio-0.10
Enterprise Value/Market Cap0.39
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.52
Forecast
1Y Price Target
$9.25Price Target Upside772.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.88
Revenue Forecast (FY)N/A
Allarity Therapeutics News
ALLR FAQ
What was Allarity Therapeutics, Inc.’s price range in the past 12 months?
Allarity Therapeutics, Inc. lowest stock price was $0.61 and its highest was $2.35 in the past 12 months.
What is Allarity Therapeutics, Inc.’s market cap?
Allarity Therapeutics, Inc.’s market cap is $19.76M.
When is Allarity Therapeutics, Inc.’s upcoming earnings report date?
Allarity Therapeutics, Inc.’s upcoming earnings report date is May 18, 2026 which is in 165 days.
How were Allarity Therapeutics, Inc.’s earnings last quarter?
Allarity Therapeutics, Inc. released its earnings results on Nov 14, 2025. The company reported -$0.19 earnings per share for the quarter, beating the consensus estimate of -$0.23 by $0.04.
Is Allarity Therapeutics, Inc. overvalued?
According to Wall Street analysts Allarity Therapeutics, Inc.’s price is currently Undervalued.
Does Allarity Therapeutics, Inc. pay dividends?
Allarity Therapeutics, Inc. does not currently pay dividends.
What is Allarity Therapeutics, Inc.’s EPS estimate?
Allarity Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Allarity Therapeutics, Inc. have?
Allarity Therapeutics, Inc. has 15,811,886 shares outstanding.
What happened to Allarity Therapeutics, Inc.’s price movement after its last earnings report?
Allarity Therapeutics, Inc. reported an EPS of -$0.19 in its last earnings report, beating expectations of -$0.23. Following the earnings report the stock price went down -0.84%.
Which hedge fund is a major shareholder of Allarity Therapeutics, Inc.?
Currently, no hedge funds are holding shares in ALLR
Company Description
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. (ALLR) is a clinical-stage biopharmaceutical company focused on developing novel oncology therapeutics. The company operates primarily in the biotechnology sector, leveraging its unique Drug Response Predictor (DRP) technology to advance its pipeline of targeted cancer treatments. Allarity is committed to identifying and developing personalized medicines that improve outcomes for patients with unmet medical needs in oncology.
ALLR Stock 12 Month Forecast
Average Price Target
$9.25
▲(772.64% Upside)
Technical Analysis
Ownership Overview
4.71% Insiders
0.58% Mutual Funds
<0.01% Other Institutional Investors
93.62% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---